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We have demonstrated previously that atria1 natriuretic factor (ANF) augments urinary, plasma nd kidney 
cGMP levels but has no significant effect upon CAMP. Using cGMP as a marker, we searched for specific 
target sites involved in the action of ANF in the dog kidney, and observed no change of cGMP in the proxi- 
mal tubules, a 2-fold increase over basal levels in the thick loop of Henle and a 3-fold elevation in the collect- 
ing duct. The most striking action on cGMP occurred in the glomeruli with a rise of up to 50-fold being 
evident at 1-2 min. after the addition of ANF. The results obtained in the absence or presence of a phospho- 
diesterase inhibitor support the notion that the effects of ANF were exerted at the level of guanylate cyclase 
stimulation rather than cGMP phosph~iesterase inhibition. The action of sodium nitroprusside (SNP), a 
direct stimulator of soluble guanylate cyciase, differed from that of ANF. The ability of the factor to en- 
hance cGMP levels was correlated with the distribution of particulate guanylate cyclase. This study identi- 
fies the glomeruli and the distal part of the nephron as specific targets of ANF and implicates particulate 
guanylate cyclase as the enzyme targetted for the expression of its action. 
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1. INTRODUCTION 
Specific secretory granules of atria1 myocytes 
contain peptides which possess potent natriureti~ 
and diuretic properties when injected into rats 
[1,2]. Several of these atria1 natriuretic factors 
(ANF) have been purified from animal and human 
sources and their sequences have been elucidated 
[3,4]. The cloning and characterization of DNA se- 
quences encoding for rat and human ANF have 
recently been accomplished [5,61, suggesting that 
these peptides are members of a family derived 
from a common precursor. A fragment of one of 
Abbreviations~ MIX, ~-methyl-3-isobutylxanthine; 
TEA, triethanolamine 
these peptides, which was synthesized recently [i’], 
exhibited activity similar to endogenous ANF. In 
addition to its diuretic and natriuretic properties, 
ANF appears to be a potent vasorelaxant [8,9] 
capable of reducing blood pressure more in spon- 
taneously hypertensive rats (SHR) than in nor- 
motensive controls (WKY) [lo]. The diminution of 
blood pressure is accompanied by greater ANF- 
induced diuresis and natriuresis in the hypertensive 
group [lo]. 
While searching for the mechanism of action of 
ANF, we recently noted a specific elevation of 
cGMP levels in plasma and urine following injec- 
tion of native ANF as well as of a synthetic ANF 
fragment Ill]. The factor also heightened cGMP 
levels in kidney slices and primary cultures of renal 
tubular cells [l 11. 
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cGMP appears to be linked to fluid and solute 
transport. Thus, diuretics such as furosemide in- 
crease cGMP levels, and injection of cGMP into 
the thoracic aorta markedly decreases tubular 
reabsorption of sodium in the rat [12]. A heat- 
stable enterotoxin from Escherichia co/i, which 
changes net sodium transport by reversal of Cl- 
flux and which abolishes net sodium absorption, 
has been shown to specifically stimulate particulate 
guanylate cyclase in the ileum [ 13,141. It has also 
been suggested that cGMP acts as a negative feed- 
back for vasocontractile agents and as a mediator 
of vascular smooth muscle relaxation [IS, 161. Our 
study was undertaken to evaluate the potential in- 
volvement of cGMP in the natriuretic and 
vasodilating properties of ANF. We therefore 
looked for the specific target sites of action of 
ANF. 
2. METHODS 
2.1. Tissue fractions 
Four different fractions (glomeruli, proximal 
tubules, thick ascending limbs, and collecting 
ducts) were obtained from dog kidneys via the 
following procedure: both kidneys were rapidly 
removed and placed in ice-cold, gassed (95% 
02/5% COZ) Krebs-Henseleit saline (KHS). They 
were cut into large sagittal slices, and the outer cor- 
tex, red medulla and white medulla were carefully 
dissected. The tissues taken from each fraction 
were then sliced with a Stadie-Riggs microtome, 
washed with KHS and placed in siliconized 
Erlenmeyer flasks containing 20 ml KHS. Lactate 
plus pyruvate (20 and 2 mM, respectively) were 
added to the cortical and red medulla slices, and 
glucose (20 mM) to the white medulla tissue. Thir- 
ty mg of collagenase (Clostridium histolyticum, 
Boehringer Mannheim) were added. The flasks 
were gassed, and the tissues incubated at 37°C for 
45 min with mechanical agitation, followed by 
tissue dissociation into tubular fragments. The cor- 
tical suspension was washed and passed through a 
90pm mesh sieve. All the glomeruli were retained 
and purified through successive washings. The rest 
of the tissues were resuspended in freshly prepared 
KHS/Percoll solution, as described elsewhere [17], 
and centrifuged at 12000 x g for 30 min. A band 
of virtually pure proximal tubules was collected 
18 
from the Percoll gradient. Thick ascending limbs 
were obtained directly from digestion of red 
medulla tissue: the vasa-recta and thin loops of 
Henle were destroyed and removed by this pro- 
cedure, which is similar to that described by 
Baverel et al. [18] except for the addition of 
substrates during the incubation with collagenase. 
The final suspension contained mostly thick as- 
cending limbs contaminated with some collecting 
ducts. A 95% pure collecting duct suspension was 
similarly derived from the white medulla. 
The following procedures verified the proper 
separation of these segments of nephrons: 
glomeruli, microscopic examination; proximal 
tubules, microscopic examination, positive PAS 
staining of brush-border membrane, rapid 
gluconeogenesis from lactate or glutamine, a small 
(10%) suppressive ffect of furosemide (0.1 mM) 
on tissue oxygen consumption; thick ascending 
limbs, microscopic examination, absence of brush- 
border membranes (PAS), absence of gluconeo- 
genesis, rapid oxidation of lactate, faster oxygen 
consumption than proximal tubules, and a major 
(60%) inhibitory effect of furosemide (0.1 mM); 
collecting ducts, microscopic examination, lack of 
oxygen uptake, fast glycolysis with stoichiometric 
release of lactate. All tissue fractions were kept on 
ice until they were utilized. 
2.2. Cyclic GMP levels 
Tissues or cells were incubated for varying time 
periods and with different concentrations of syn- 
thetic ANF. Incubation was terminated with the 
addition of an equal volume of 1 N perchloric 
acid. cGMP levels were measured by radioim- 
munoassay [19] after purification on Al203 and 
Dowex columns. 
2.3. Guanylate cyclase activity 
This parameter was essentially assessed as 
described earlier [20]. The reaction mixture 
(0.1 ml) contained 2 mM dithiothreitol, 5 mM 
creatinine phosphate, 50 pg creatinine phosphoki- 
nase, 1 mM MIX, 5 mM MnClz, 2 mM cGMP, 
0.5 mM GTP, 0.1-0.5 ,&i [a-32P]GTP in 50 mM 
Tris buffer (pH 7.5) and l-5 pg enzyme protein. 
The activities were linear for at least 60 min. In- 
cubation was stopped after 30 min at 37°C by the 
addition of 500~1 of 120 mM zinc acetate and 
600 ~1 sodium carbonate. After centrifugation, the 
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[32P]cGMP formed was further purified on Dowex 
WX4 and alumina columns. 
too r
2.4. Enzyme preparation 
After resuspension in 20 mM TEA and 1 mM 
EDTA (pH 7.5), the tissues were processed in a 
Polytron homogenizer. The homogenates were 
centrifuged twice at 30000 x g for 30 min, and the 
pellets were redissolved in TEA buffer. Super- 
natants and particulate fractions were incubated at 
37°C for 30 min with GTP-Mn as substrate, as 
described previously. Proteins were measured by 
the method of Lowry et al. 1211 with bovine serum 
albumin as standard. 
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3. RESULTS AND DISCUSSION 
I 2 3 4 
TIME fmlnl 
3.1. Effect of ANF on cGMP levels in different 
fractions of dog nephron 
cGMP levels were assessed at varying time inter- 
vals after the addition of 0.5 4M synthetic ANF to 
four different fractions of the dog nephron. We 
observed no effect in the proximal tubules, a 2-fold 
increase over basal values in the thick ascending 
loop of Henle, and a 3-fold elevation of cGMP in 
the collecting ducts (fig.1). The most dramatic 
change was evident in the glomeruli with a max- 
imal 50-fold augmentation over basal cGMP levels 
occurring at l-2 min after ANF was added (fig. 1). 
The threshold concentration of ANF for the 
cGMP rise was 5 nM (fig.2). A 4-fold enhance- 
ment of cGMP in glomeruli was recorded with 
100 nM ANF and this was not significantly 
modified by 0.5 mM of MIX, a cyclic nucleotide 
phosphodiesterase inhibitor (fig.2). In contrast, in 
the thick loop of Henle and in the collecting duct, 
the heightened cGMP levels, starting with a con- 
centration of 5-10 nM ANF, were visible only in 
the presence of MIX (fig.2). The relative influence 
of cGMP-hydrolyzing activity on resting cGMP 
levels appeared to be greater in the two latter frac- 
tions since the addition of MIX alone raised the 
cGMP values by 2-fold in these tissues. In the pro- 
ximal tubules, ANF had no effect upon cGMP 
levels up to a concentration of 5 FM, either in the 
absence or presence of MIX. 
Fig. 1. Time course of effect of ANF on cGMP levels. 
Four fractions of dog kidney, processed as described in 
section 2, were incubated at 37°C with constant 
agitation in the absence or presence of 0.5 pM ANF. The 
incubation was stopped at different time intervals with 
the addition of an equal volume of 1 N perchloric acid. 
cCMP levels were measured by radioimmunoassay. The 
basal values of cGMP were 0.5 pmol-mg protein-r in 
the proximal tubules, 2 pmol-mg protein-’ in the 
collecting ducts, 7 pmol.mg protein-’ in the thick loop 
of Henle, and S pmol.mg protein-’ in glomeruli. 
Results are the mean of two different experiments. 
in the proximal tubules. The differential responses 
of cGMP to ANF correlate well with the presence 
and density of ANF receptors in the same tissues 
(De Lean et al., in preparation). Our data on the 
influence of MIX support the hypothesis that the 
effects of ANF are exerted at the level of guanylate 
cyclase stimulation rather than cGMP phospho- 
diesterase inhibition. This, however, does not 
preclude a contributing inhibitory action of ANF 
on cGMP phosphodiesterase, as reported pre- 
viously [ 111. 
3.2. Comparison of effects of sodium 
nitroprusside (SNP) and ANF on cCMP 
levels 
These results demonstrate that ANF preferen- We compared the actions of ANF on cGMP 
tially enhances cGMP levels in the glomeruli, leveis in glomeruli and in the thick loop of Henle 
followed by Iower elevations in the collecting duct with those of SNP, a potent stimulator of soluble 
and thick loop of Henie, with no detectable change guanylate cyclase. As shown in fig.3, the increase 
19 
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Fig.2. Dose-response curves of cGMP increase by ANF. 
The tissues were incubated with increasing 
concentrations of ANF for 2 min at 37°C in the absence 
(0) or presence (0) of 0.5 mM MIX. Results are the 
mean of 3 different experiments. 
of cGMP by SNP in the glomeruli was lower than 
that elicited by ANF up to a concentration of 
1OOpM SNP. Furthermore, the augmentation of 
cGMP by SNP was enhanced by the presence of 
MIX. Glomerulus-derived cells, cultured from 
outgrowths of isolated dog glomeruli revealed 
similar responses as seen in fresh tissues (not 
shown). In contrast, in the thick loop of Henle 
(fig.3), and in collecting ducts (not shown), the in- 
crease of cGMP levels by SNP was three times 
greater than that induced by ANF. 
We detected no effect of ANF on cGMP in rat 
platelets, but a 4-fold elevation was generated by 
25 ,uM SNP (not shown). ANF did not raise cGMP 
levels despite the presence of ANF receptors in this 
cell type (Schiffrin et al., under preparation). On 
the other hand, in primary cultures of rat 
mesenteric vascular smooth muscle cells, a similar 
IO-fold increase of cGMP values was induced with 
100 nM ANF or 100/M SNP (table 1). In this 
tissue, the threshold concentration of ANF for the 
cGMP increase was 0.1 nM. 
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Fig.3. Effects of SNP and ANF on cGMP levels in 
glomeruli and the thick loop of Henle. Glomeruli and 
the thick loop of Henle were incubated, as described 
previously, with increasing concentrations of ANF (left) 
or SNP (right) in the absence or presence of 0.1 mM 
MIX. 
Table 1 
Effect of ANF and SNP on cGMP levels in rat 
mesenteric vascular smooth muscle cells 
ANF cGMPa SNP cGMPa 
(nM) levels OtM) levels 
0 0.5 0 0.6 
0.1 0.7 0.1 0.6 
1.0 1.1 1.0 0.7 
10 4.9 10 1.5 
100 4.9 100 5.6 
a cGMP levels are expressed in pmol.mg protein-’ 
Mesenteric vascular smooth muscle cells were obtained 
from adult Wistar rats by collagenase treatment. The 
cells were kept in medium supplemented with 10% 
bovine serum and containing penicillin (100 fig/ml) and 
streptomycin (200 pug/ml). At the time of the 
experiment, the cell cultures showed about 90% 
confluence. These experiments were performed on cells 
between 3-5 passages 
20 
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The results described up to now illustrate signifi- 
cant differences in the ability of SNP and ANF to 
augment cGMP levels in the tissues examined. 
SNP enhanced cGMP values more than ANF in 
the thick loop of Henle, in the collecting duct, and 
in platelets. In contrast, the elevation of cGMP 
levels by ANF was greater than that elicited by 
SNP in glomeruli and similar to that caused by 
SNP in rat mesenteric vascular smooth muscle 
cells. 
3.3. ~~stri~utio~ of gua~ylate cyclase activity in 
dog kidney 
The cellular distribution of soluble and par- 
ticular guanylate cyclases varies from tissue to 
tissue. For example, in platelets, over 95% of 
guanylate cyclase recovers in platelet supernatants 
[20], whereas in the intestine most of it is in par- 
ticulate form. In whole kidney homogenate, 90% 
of guanylate cyclase recovers in the soluble frac- 
tion. Craven and DeRubertis [22] have reported 
that guanylate cyclase is mostly soluble in the renal 
cortex but is particulate in the medulla. Helwig et 
al. [23] recorded a higher activity of particulate 
guanylate cyclase in rabbit glomeruli, while 
tubular preparations registered mainly soluble ac- 
tivity. The hormones and hormone-like agents 
tested had no effect on these enzymes [23]. cGMP 
levels were increased in the glomeruli by 
cholinergic agents and nitroso reagents in studies 
by Dousa et al. [24]. 
We determined the distribution of guanylate 
cyclase activity in the four fractions of dog kidney 
(table 2). In the glomeruli, over 80% of guanylate 
cyclase was found in particulate form, whereas 
only 20% was noted in this fraction of the collect- 
ing duct and the thick loop of Henle. In the prox- 
imal tubules, total guanylate cyclase activity was 
very low and not detectable in the particulate frac- 
tion. Thus, a good correlation exists between the 
ANF-induced elevation of cGMP levels and the 
distribution of particulate guanylate cyclase. The 
fact that ANF stimulates cGMP formation dif- 
ferently than SNP and is more potent in tissues 
rich in particulate guanylate cyclase had led us to 
suggest that ANF raises cGMP levels in specific 
target cells by stimulation of particulate guanylate 
cyclase. 
The direct action of ANF on particulate 
guanylate cyclase is difficult to demonstrate in cell- 
Table 2 
Distribution of guanylate cyclases in dog kidney 
Supernatant Particulate 
(pmol cGMP . min- ’ * mg-‘) 
Glomeruli 
Collecting duct 
Loop of Henle 
Proximal tubule 
a Not detectabte 
83 392 
91 28 
39 10 
2 n/d” 
Supernatant and pa~iculate fractions were obtained by 
centrifugation of whole homogenate twice at 30000 X 8 
free systems. However, our preliminary data in- 
dicate a two-fold stimulation of dog glomerulus 
particulate guanylate cyclase by ANF with no 
manifest effect upon the soluble fraction (Gerzer et 
al., in preparation). 
Numerous hormonal factors, including muscar- 
inic and cr-adrenergic agonists, have been shown to 
stimulate cellular cGMP formation. In many 
tissues, the stimulation involves calcium and the 
release of arachidonic acid 1201. The guanylate 
cyclase stimulated is the soluble type, which can 
also be stimulated by non-hormonal compounds. 
Non-hormonal stimulation by agents such as 
nitroso compounds does not require calcium and 
can be demonstrated irectly, in cell-free systems, 
on soluble or, to a lesser extent, on particulate 
guanylate cyclase [25]. 
Only a few agents have been found to stimulate 
particulate guanylate cyclase. A heat-stable 
enterotoxin from E. coli stimulates intestinal par- 
ticulate guanylate cyclase but is ineffective in other 
tissues 113,141. Speract, a decapeptide, binds to 
spermatozoa and increases cGMP concentrations 
in these cells in which particulate guanylate cyclase 
is predominant [26]. However, no direct stimula- 
tion of the particulate fraction has been 
demonstrated with this agent. 
The present study identifies glomeruli and the 
distal part of the nephron as specific targets for 
ANF and indicates that particulate guanylate 
cyclase is the target enzyme involved in the action 
of ANF. In vascular smooth muscle celfs, where 
both particulate and soluble guanylate cyclases are 
present, both ANF and SNP are vasodilatory. In 
the kidney, however, the effect of ANF appears to 
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